View Grant Opportunity
Impact of Initial Influenza Exposure on Immunity in Infants (U01 Clinical Trial Not Allowed)
National Institutes of Health
RFA-AI-27-019
HHS-NIH11
General Information
$9,600,000
Est. Program Funding:
Est. Program Funding:
June 4, 2026
Closing Date:
Closing Date:
3
Expected No. of Awards
Expected No. of Awards
$3,000,000
Award Ceiling
Award Ceiling
Opportunity Number:
RFA-AI-27-019
Owning Agency:
HHS-NIH11
Opportunity Category:
Discretionary (D)
Synopsis
| The purpose of this notice of funding opportunity (NOFO) is to support the establishment or continuation of longitudinal infant cohorts to determine and compare how initial and repeated natural influenza infections and/or influenza vaccinations shape infant and childhood immunity to future influenza exposures. The goal of this research is to understand how these exposures influence immune responses to subsequent influenza infections and/or vaccines and provide key information to facilitate design of durable, broadly protective influenza vaccines. | |
| Response Date | Jun 04, 2026 12:00:00 AM EDT |
| Posting Date | Feb 10, 2026 12:00:00 AM EST |
| Archive Date | Aug 03, 2026 12:00:00 AM EDT |
| Award Ceiling | 3,000,000 |
| Award Floor | N/a |
| Cost Sharing | No |
Eligibility
| Eligible Applicants | City or township governments, Independent school districts, Native American tribal organizations (other than Federally recognized tribal governments), Small businesses, Public housing authorities/Indian housing authorities, Others (see text field entitled "Additional Information on Eligibility" for clarification), Special district governments, County governments, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, State governments, Private institutions of higher education, For profit organizations other than small businesses, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Info on Eligibility: | Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. This new requirement was effective, May 1, 2025.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors. |
Additional Information
| Agency Name | National Institutes of Health |
| Link to Additional Information: | N/a |
| Grantor Contact Information: |
If you have difficulty accessing the full announcement electronically, please contact:
GrantSolutions Help Desk Phone: 301-402-2541 |
CFDA Program(s)
- 93.855: Allergy and Infectious Diseases Research
Contact Us
Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.